ELAN
Price
$24.53
Change
+$0.35 (+1.45%)
Updated
Jan 16 closing price
Capitalization
12.19B
39 days until earnings call
Intraday BUY SELL Signals
VTRS
Price
$12.86
Change
+$0.02 (+0.16%)
Updated
Jan 16 closing price
Capitalization
14.81B
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELAN vs VTRS

Header iconELAN vs VTRS Comparison
Open Charts ELAN vs VTRSBanner chart's image
Elanco Animal Health
Price$24.53
Change+$0.35 (+1.45%)
Volume$6.59M
Capitalization12.19B
Viatris
Price$12.86
Change+$0.02 (+0.16%)
Volume$8.77M
Capitalization14.81B
ELAN vs VTRS Comparison Chart in %
ELAN
Daily Signal:
Gain/Loss:
VTRS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ELAN vs. VTRS commentary
Jan 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and VTRS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 17, 2026
Stock price -- (ELAN: $24.53 vs. VTRS: $12.86)
Brand notoriety: ELAN: Notable vs. VTRS: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 126% vs. VTRS: 103%
Market capitalization -- ELAN: $12.19B vs. VTRS: $14.81B
ELAN [@Pharmaceuticals: Generic] is valued at $12.19B. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $14.81B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.06B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 1 FA rating(s) are green whileVTRS’s FA Score has 3 green FA rating(s).

  • ELAN’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 3 green, 2 red.
According to our system of comparison, VTRS is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 6 TA indicator(s) are bullish while VTRS’s TA Score has 2 bullish TA indicator(s).

  • ELAN’s TA Score: 6 bullish, 4 bearish.
  • VTRS’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than VTRS.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а +4.52% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was +0.78% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.04%. For the same industry, the average monthly price growth was +6.33%, and the average quarterly price growth was +18.14%.

Reported Earning Dates

ELAN is expected to report earnings on Feb 25, 2026.

VTRS is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.04% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.8B) has a higher market cap than ELAN($12.2B). ELAN has higher P/E ratio than VTRS: ELAN (350.43) vs VTRS (236.20). ELAN YTD gains are higher at: 8.396 vs. VTRS (3.293). ELAN has higher annual earnings (EBITDA): 840M vs. VTRS (-598.9M). VTRS has more cash in the bank: 1.16B vs. ELAN (505M). ELAN has less debt than VTRS: ELAN (4.02B) vs VTRS (14.7B). VTRS has higher revenues than ELAN: VTRS (14.1B) vs ELAN (4.59B).
ELANVTRSELAN / VTRS
Capitalization12.2B14.8B82%
EBITDA840M-598.9M-140%
Gain YTD8.3963.293255%
P/E Ratio350.43236.20148%
Revenue4.59B14.1B33%
Total Cash505M1.16B44%
Total Debt4.02B14.7B27%
FUNDAMENTALS RATINGS
ELAN vs VTRS: Fundamental Ratings
ELAN
VTRS
OUTLOOK RATING
1..100
2683
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9096
PRICE GROWTH RATING
1..100
399
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (11) in the null industry is significantly better than the same rating for ELAN (94) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew significantly faster than ELAN’s over the last 12 months.

VTRS's Profit vs Risk Rating (100) in the null industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's SMR Rating (90) in the Agricultural Commodities Or Milling industry is in the same range as VTRS (96) in the null industry. This means that ELAN’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's Price Growth Rating (9) in the null industry is in the same range as ELAN (39) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew similarly to ELAN’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is in the same range as ELAN (2) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew similarly to ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANVTRS
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
53%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 5 days ago
65%
Bullish Trend 9 days ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
64%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ELAN
Daily Signal:
Gain/Loss:
VTRS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AJUL29.190.02
+0.09%
Innovator Eq Dfnd Prot ETF - 2Yr toJul26
HYGV41.010.01
+0.02%
FlexShares HY Val-Scrd Bd
TAFL25.14-0.04
-0.14%
AB Tax-Aware Long Municipal ETF
FSCS37.13-0.13
-0.35%
First Trust SMID Capital Strength ETF
FXZ72.22-0.59
-0.81%
First Trust Materials AlphaDEX® ETF